Evidence trail · Related option, assessed separately

Existing-firm management and technology adoption

Delivery risk: AmberFurther checks needed

Not stated in the review record; treated as a provisional single-reviewer assessment, not an approved business case.

Scoring overview · equal weights

Range if completed: 15 to 21 out of 30 (equal weights). Not yet assessed: expected incremental benefit, incremental affordability.

← Back to the planOn its topic page: Innovation →

The golden thread for this option, step by step. A dashed step is missing — shown as a gap, never filled in. Provisional single-reviewer assessment; not an approved business case, and not government policy.

  1. Step 1: Topic headlineIn place

    Innovation

    £79bn on research. Spending is only the beginning.

    Priority: Help more research and existing technology reach wider use, where a specific barrier can be shown and fixed. What would change it →

  2. Step 2: Deep diveMissing

    Innovation has no chapter pages of its own; its evidence is on the topic page.

  3. Step 3: EvidenceIn place

    Business-advice evaluations show mixed results, with turnover effects more consistent than productivity/employment. Do not assume every AI or digital adoption subsidy works.

    Sources: whatworksgrowth.org

    The action record · experimental or quasi-experimental evaluation

    Free intensive consulting raised productivity by about 11% in the Indian trial; Help to Grow: Management found “no statistically significant evidence of business growth or improved firm-level productivity”; 14 of 23 business-advice evaluations found a positive effect on at least one outcome, more often turnover than productivity.

    Sources: NBER Working Paper 16658 (2011); Quarterly Journal of Economics (2013), Does management matter? Evidence from India (Abstract); Department for Business and Trade (Ipsos and IES); now BIST, Help to Grow: Management phase 1 final evaluation report (process and impact) (Executive summary p.5; Table 23); What Works Centre for Local Economic Growth, Evidence review: business advice (Summary of findings)

    8 October research follow-up · AI-assisted

    Business advice evidence is mixed and foreign management trials do not provide a UK-wide productivity forecast.

    The proposed design, costing task and safeguards are in the assessment below. These sources do not make an incomplete appraisal complete.

  4. Step 4: Competing optionsIn place

    Funded now (current baseline)
    Funded baseline: Help to Grow: Management (participants pay £750) continues; Made Smarter Adoption runs in all nine English regions (£16m in 2025–26); the Business Growth Service is the national brand. A comparison-based test of diagnostic and adoption support with a productivity outcome is a UK Facts proposal, not government policy.
    The change assessed
    Test targeted diagnostic advice and adoption support for existing firms, with a comparator and a defined productivity outcome.

    Other options assessed on Innovation

    • Turn research into products and adoption

      Delivery risk: AmberFurther checks needed

      Research and adoption

      Turn research into products and adoption

      Owner: Business/research departments, UKRI and public buyers. Cost: Administration, grants, procurement risk and private match; estimate displacement and additional private investment..

      Assessment range and limitations

      Range if completed: 11 to 20 out of 30 (equal weights). Not yet assessed: increment beyond baseline, expected incremental benefit, incremental affordability.

      Topic: Innovation

    Alternatives already on record on the topic page: 23 under its SWOT points and 4 earlier options compared, not scored in the review. See them on Innovation.

  5. Step 5: SWOT points it addressesIn place

  6. Step 6: The action and its assessmentIn place

    The action card on Innovation: Existing-firm management and technology adoption

    A69Delivery risk: AmberGate: pending

    Existing-firm management and technology adoption

    Existing action A69, assessed at the same scope.

    Not stated in the review record; treated as a provisional single-reviewer assessment, not an approved business case.

    Who and where
    Established small and medium-sized firms in England with 10 or more employees in sectors with low management scores, in mayoral areas running the Business Growth Service. (from the action record) Jurisdiction: England.
    Result so far
    Range if completed: 15.0–21.0 out of 30 (equal weights; not yet assessed: expected incremental benefit (Bn), incremental affordability (Co))
    Funded now (baseline)
    Funded baseline: Help to Grow: Management (participants pay £750) continues; Made Smarter Adoption runs in all nine English regions (£16m in 2025–26); the Business Growth Service is the national brand. A comparison-based test of diagnostic and adoption support with a productivity outcome is a UK Facts proposal, not government policy. (from the action record)
    The change assessed (marginal)
    Test targeted diagnostic advice and adoption support for existing firms, with a comparator and a defined productivity outcome. (from the 6 October review)
    What the evidence supports—and the next decision

    Business advice evidence is mixed and foreign management trials do not provide a UK-wide productivity forecast.

    AI-assisted analytical follow-up · 8 October 2026. Proposed appraisal design; the attributed scores below are unchanged. No funding or delivery agreement is implied.

    Define the change
    Test targeted diagnostics and adoption support for a defined firm group against the existing support offer.
    Test whether it works
    Additional productivity, survival and adoption with comparison firms; separate turnover growth from productivity and examine spillovers.
    Establish the cost
    Advisers, grants, firm time, technology and evaluation, net of fees; test whether firms would have invested anyway.
    Protect against harm
    Use transparent eligibility and publish failures; avoid subsidising adoption already planned.

    Read with the outcome evidence and sources in the full assessment. Monitoring proposals are not existing baseline measurements. A numerical benefit or cost score needs evidence for the defined increment, not just the scale of the problem.

    Full assessment of Existing-firm management and technology adoption: ten criteria, scenarios, delivery, costs and monitoring

    The ten criteria (0–3)

    Each criterion is scored 0 to 3 by the reviewer. “Not yet assessed” means unknown: it is never counted as zero.

    1. Scale and severity (Sc)2 of 3 — Serious harm to a defined group or widespread moderate harm

    2. Increment beyond baseline (Ad)2 of 3 — Specific material change to existing delivery

    3. Confidence in the proposed action (Ev)1 of 3 — Indirect, mixed, modelled or weak causal support

    4. Expected incremental benefit (Bn)Not yet assessed

    5. Residual harms (Hm)2 of 3 — Manageable harm with specified safeguards

    6. Incremental affordability (Co)Not yet assessed

    7. Delivery capacity (Ca)2 of 3 — Stretched but plausibly obtainable

    8. Distribution (Fa)2 of 3 — Mixed or broadly neutral with safeguards

    9. Meaningful first outcome (Ti)2 of 3 — More than one and up to three years

    10. Readiness (Rd)2 of 3 — Named commissioning/allocation/coordination step

    Four weightings

    Normalised as 10 × weighted sum ÷ sum of weights, on a 0–30 scale. Where a criterion is not yet assessed, the range is the lowest and highest result if it were later scored 0 or 3 — not a score, a confidence interval or a rank.

    • Equal weights: Range if completed: 15.0–21.0 out of 30. Not yet assessed: expected incremental benefit (Bn), incremental affordability (Co). Funding gate: not passed.
    • Evidence doubled: Range if completed: 14.5–20.0 out of 30. Not yet assessed: expected incremental benefit (Bn), incremental affordability (Co). Funding gate: not passed.
    • Scale doubled: Range if completed: 15.5–20.9 out of 30. Not yet assessed: expected incremental benefit (Bn), incremental affordability (Co). Funding gate: not passed.
    • Cost ignored (the funding gate still applies): Range if completed: 16.7–20.0 out of 30. Not yet assessed: expected incremental benefit (Bn), incremental affordability (Co). Funding gate: not passed.

    Funding gate: Not passed — the cost is not yet assessed or no allocation is committed for this scope. Ignoring cost in a weighting never removes the gate.

    Delivery risk and gate

    Delivery risk shown: AmberReview’s claim: Amber. Best the recorded evidence allows: Amber.

    Review’s reason: Define firm eligibility and existing offer; cost advisers, adoption support and evaluation, including firm contributions. Measure additional productivity, survival and displacement. Proposed owners: business department, local business-support bodies and delivery partners.

    Why it is not Green yet

    • Scope (population, place and increment) not verified against the delivery baseline.
    • No verified owner with the powers in place.
    • Delivery capacity not verified.
    • Lifetime incremental costs not complete.
    • No credible funding (a committed allocation for the scope).
    • Safeguards not specified.
    • Monitoring lacks a metric, a data source or a baseline.

    Green needs verified scope, a verified owner with the powers, verified capacity, complete lifetime costs with credible funding, specified safeguards and monitoring with a metric, source and baseline. Amber means appraisal gaps remain; Red means a material delivery obstacle. Red does not mean unimportant.

    Gate: Pending — appraisal incomplete (review label: “Pending baseline verification, incremental costing and funding; not a rollout approval”).

    Why: Scores incomplete; Funding gate not passed (cost unknown or no credible funding).

    The gate is separate from national list membership: being listed does not make an option eligible, and an eligible option need not be listed.

    Cost and funding

    Lifetime costing: Not established. Review: “Not fully costed in this review”.

    Still to cost: Define firm eligibility and existing offer; cost advisers, adoption support and evaluation, including firm contributions. Measure additional productivity, survival and displacement. Proposed owners: business department, local business-support bodies and delivery partners.

    Funding status: not identified.

    Owner, powers and capacity

    Proposed owner: business department, local business-support bodies and delivery partners (proposed, unverified).

    Powers: needs a decision or allocation. Capacity: unverified.

    Powers and capacity read from the review’s Rd and Ca anchors; no proposed owner has agreed to act (the review: “Proposed owners have not agreed to act”).

    England:
    Department for Business, Innovation, Science and Trade (formerly DBT) with mayoral strategic authorities and Growth Hubs (action record)
    Scotland:
    not assessed
    Wales:
    not assessed
    Northern Ireland:
    not assessed

    Business support is devolved in Scotland, Wales and Northern Ireland; Help to Grow: Management runs UK-wide. Not assessed outside England.

    Dependencies, safeguards and risks

    Depends on: None recorded.

    Safeguards

    None specified yet.

    Monitoring and measured results

    Metric: Define and baseline the outcome described in delivery requirements before approval.

    Data source: Not yet named. Baseline: Not yet established.

    Measures already on the domain page

    A page measure is not necessarily the review’s metric; linking the two is an editorial decision still to be made.

    Evidence for the outcome

    Outcome: Define and baseline the outcome described in delivery requirements before approval.

    Business-advice evaluations show mixed results, with turnover effects more consistent than productivity/employment. Do not assume every AI or digital adoption subsidy works.

    Sources: whatworksgrowth.org (P-GC-WWG-ADVICE-2016)

    Review record

    Assessment status: Not stated in the review record; treated as a provisional single-reviewer assessment, not an approved business case.

    Reviewer: Original assessment author (name not supplied). Reviewed: 6 October 2026.

    Scored in the working review of 6 October 2026 on the shared ten-criterion scale (one reviewer); not independently calibrated.

    An editorial screening framework by one reviewer, not a formal appraisal or business case. Proposed owners have not agreed to act.

  7. Step 7: Measured resultsPartly in place

    Judged on: Define and baseline the outcome described in delivery requirements before approval.

    Data source: not yet named. Baseline: not yet established.

    A page measure is not necessarily the option’s metric, and a measure moving is not proof that the option caused it.